118 related articles for article (PubMed ID: 7844688)
1. Infectious hazards of immune globulin.
Barton LL
J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
[No Abstract] [Full Text] [Related]
2. The safety of immune globulins.
Tepper M; Gully P
Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
[No Abstract] [Full Text] [Related]
3. Long-term surveillance of HIV, HBV, and HCV infected patients.
Shapiro A
Ann Hematol; 1994; 68 Suppl 3():S87-8. PubMed ID: 8180264
[No Abstract] [Full Text] [Related]
4. Hepatitis C and immune globulin.
Douglas SD; Slade HB
N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
[No Abstract] [Full Text] [Related]
5. Hepatitis C and immune globulin.
López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
[No Abstract] [Full Text] [Related]
6. Hepatitis C and immune globulin.
Prince AM; Horowitz B
N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
[No Abstract] [Full Text] [Related]
7. Transmission of viral infections through intravenous immune globulin.
Schiff RI
N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
[No Abstract] [Full Text] [Related]
8. Transmission of hepatitis after the administration of intravenous immunoglobulins.
Rousell RH; Dobkin MB; Budinger MD; Louie RE
Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
[No Abstract] [Full Text] [Related]
9. Hepatitis C transmission associated with intravenous immunoglobulins.
Yu MW; Mason BL; Guo ZP; Tankersley DL; Nedjar S; Mitchell FD; Biswas RM
Lancet; 1995 May; 345(8958):1173-4. PubMed ID: 7536874
[No Abstract] [Full Text] [Related]
10. Hepatitis C transmission associated with intravenous immunoglobulins.
Nübling CM; Willkommen H; Löwer J
Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
[No Abstract] [Full Text] [Related]
11. Hepatitis C from immunoglobin infusions.
Lehner PS; Webster AD
BMJ; 1993 Jun; 306(6891):1541-2. PubMed ID: 8518699
[No Abstract] [Full Text] [Related]
12. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
Yu MW
Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139
[No Abstract] [Full Text] [Related]
13. [Hepatitis C following administration of intravenous immunoglobulins].
Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T
N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215
[TBL] [Abstract][Full Text] [Related]
15. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
Am J Hosp Pharm; 1994 Oct; 51(19):2326. PubMed ID: 7847397
[No Abstract] [Full Text] [Related]
16. Side-effects of intravenous immune globulins.
Duhem C; Dicato MA; Ries F
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus transmission by intravenous immunoglobulin.
Farrugia A; Walker E
Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
[No Abstract] [Full Text] [Related]
18. Hepatitis C virus transmission by intravenous immunoglobulin.
James RC; Mosley JW
Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
[No Abstract] [Full Text] [Related]
19. HCV and Gammagard in France.
Gomperts ED
Lancet; 1994 Jul; 344(8916):201. PubMed ID: 7912801
[No Abstract] [Full Text] [Related]
20. Hepatitis C virus and intravenous immune globulin.
Mosley JW
JAMA; 1997 Feb; 277(8):627; author reply 627-8. PubMed ID: 9039875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
